Table 3.
12 weeks | 16 weeks | ||||||
---|---|---|---|---|---|---|---|
Control | HFD60 | WD | Control | HFD60 | WD | ||
NAS | NAS | 1 ± 0.89 | 3.67 ± 1.03 | 5.83 ± 0.75 | 0.83 ± 0.41 | 4.33 ± 1.21 | 5.5.±1.64 |
Steatosis | 0 | 1.33 ± 0.52 | 3 | 0 | 1.33 ± 0.52 | 2.67 ± 0.52 | |
Inflammation | 1.0 ± 0.89 | 0.83 ± 0.41 | 1.83 ± 0.75 | 0.83 ± 0.41 | 2 | 1.83 ± 0.75 | |
Ballooning | 0 | 1.5 ± 0.55 | 1 | 0 | 0.83 ± 0.75 | 1.0 ± 0.63 | |
| |||||||
Fibrosis | Fibrosis score | 0 | 0.17 ± 0.41 | 1.5 ± 0.55 | 0.5 ± 0.55 | 1.2 ± 0.41 | 2.7 ± 1.5 |
Sirius red | 0.62 ± 0.13 | 1.01 ± 0.579 | 1.79 ± 0.99 | 0.73 ± 0.2 | 1.27 ± 0.41 | 2.24 ± 0.41 | |
| |||||||
Inflammation | F4/80 | 17 ± 5.2 | 30 ± 6.9 | 38 ± 2.4 | 12 ± 2.2 | 26 ± 10 | 31 ± 5.3 |
Ly6G | 6.7 ± 1.3 | 9.6 ± 2.69 | 15.4 ± 4.53 | 6.56 ± 1.09 | 10.63 ± 1.9 | 8.33 ± 1.24 |